Global /Italy /Healthcare /Drug Manufacturers - Specialty & Generic /PHN
chevron_leftBack

Pharmanutra S.p.A.

PHN
MIL: PHN Delayed
50.90EUR 0.8%
57.68 USD
As of 24 April 2025, Pharmanutra S.p.A. has a market cap of $551.87M USD, ranking #11421 globally and #97 in Italy. It ranks #1112 in the Healthcare sector, and #269 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
11421
Country Rank
97
Sector Rank
1112
Industry Rank
269
Key Stats
Market Cap
$551.87MUSD
484.96M EUR
Enterprise Value
$544.12MUSD
480.14M EUR
Revenue (TTM)
$132.17MUSD
116.15M EUR
EBITDA (TTM)
$34.27MUSD
30.24M EUR
Net Income (TTM)
$18.9MUSD
16.61M EUR
EBITDA Margin
26%
Profit Margin
14%
PE Ratio
29.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Roberto Lacorte open_in_new
Employees
118
Founded
2003
Website
pharmanutra.it open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.8% -0.6% 2.5% -3.6% -11% -4.2%

Markets

Exchange Ticker Price
Borsa Italiana
MIC: XMIL
PRIMARY
PHN
PharmaNutra SpA
ISIN: IT0005274094
Shares Out.:
9.603M1 Shares Float: 3.116M2
TV:
SA:
YF:
GF:
BA:
PHN
MS:
50.90 EUR
Frankfurt Stock Exchange
MIC: XFRA
761
PharmaNutra SpA
ISIN: IT0005274094
TV:
SA:
YF:
GF:
BA:
761
MS:
50.70 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Pharmanutra S.p.A.

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also sells machinery and instruments for measuring body bioimpedance, as well as offers ophthalmic products. The company offers its products for iron defiency, inflammations, and night rest. It sells its products under the PharmaNutra, Alesco and Akern brands. The company distributes its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
12K%
Merck KGaA
MRK
$59.67B
52.43B EUR
11K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
9K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
8K%
Haleon plc
HLN
$45.68B
34.34B GBP
8K%